Login to Your Account



Other News To Note


Wednesday, December 26, 2012
• Cubist Pharmaceuticals Inc., of Lexington, Mass., submitted a supplemental new drug application to the FDA for Entereg (alvimopan) for gastrointestinal recovery after bowel resection with primary anastamosis.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription